๎
๎ผ
๋ก๊ทธ์ธ
๎
PolyPid Ltd
PYPD4.340USD
+0.060+1.40%
์์ฅ ์ด์ ์๊ฐย ๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
79.01M์๊ฐ์ด์ก
์์คP/E TTM
๎
์์ธํ ๋ด์ฉ์ PolyPid Ltd ํ์ฌ
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
PolyPid Ltd ์ ๋ณด
๎์ข
๋ชฉ ์ฝ๋ PYPD
ํ์ฌ ์ด๋ฆPolyPid Ltd
์์ฅ์ผJun 26, 2020
CEOAkselbrad (Dikla Czaczkes)
์ง์ ์57
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃJun 26
์ฃผ์18 Hasivim Street, P.O Box 7126
๋์PETAH TIKVA
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐIsrael
์ฐํธ ๋ฒํธ4917002
์ ํ972747195700
์น์ฌ์ดํธhttps://www.polypid.com
์ข
๋ชฉ ์ฝ๋ PYPD
์์ฅ์ผJun 26, 2020
CEOAkselbrad (Dikla Czaczkes)
PolyPid Ltd์ ํ์ฌ ์์์ง
๎์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
--
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mrs. Anat Tsour Segal
Mrs. Anat Tsour Segal
Independent Director
Independent Director
--
--
Dr. Shaul Mukhtar, Ph.D.
Dr. Shaul Mukhtar, Ph.D.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Ms. Dalit Hazan
Ms. Dalit Hazan
Senior Vice President - Research and Development and Regulatory Affairs
Senior Vice President - Research and Development and Regulatory Affairs
--
--
Mr. Nir Dror
Mr. Nir Dror
Independent Director
Independent Director
--
--
๋ ๋ณด๊ธฐ
์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
--
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
์์ต ๋ถ์
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ฌ์
๋ณ
์ง์ญ๋ณ
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Mar 14
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Mar 14
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Aurum Ventures M.K.I.
16.15%
Hodges (Rodney)
10.71%
AIGH Capital Management, LLC.
6.03%
Centaurus Investments Limited
5.80%
Rosalind Advisors, Inc.
3.65%
๊ธฐํ
57.65%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Aurum Ventures M.K.I.
16.15%
Hodges (Rodney)
10.71%
AIGH Capital Management, LLC.
6.03%
Centaurus Investments Limited
5.80%
Rosalind Advisors, Inc.
3.65%
๊ธฐํ
57.65%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Venture Capital
16.33%
Individual Investor
15.53%
Hedge Fund
6.24%
Private Equity
6.03%
Holding Company
5.80%
Research Firm
1.22%
Investment Advisor
1.12%
Investment Advisor/Hedge Fund
1.00%
๊ธฐํ
46.73%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Jan 1
๋ง์ง๋ง ์
๋ฐ์ดํธ: Thu, Jan 1
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2025Q4
32
6.78M
40.77%
+1.48M
2025Q3
28
6.76M
43.18%
+2.23M
2025Q2
41
7.60M
74.58%
+1.39M
2025Q1
42
7.66M
75.16%
+942.60K
2024Q4
44
5.48M
65.20%
+1.87M
2024Q3
50
4.47M
69.98%
+1.49M
2024Q2
58
3.43M
73.51%
+1.59M
2024Q1
59
3.33M
71.29%
+2.56M
2023Q4
54
443.78K
34.10%
+80.67K
2023Q3
57
479.04K
37.01%
+97.48K
๋ ๋ณด๊ธฐ
์ฃผ์ฃผ ํ๋
๎์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
Aurum Ventures M.K.I.
3.08M
18.53%
+1.06M
+52.19%
Jun 30, 2025
AIGH Capital Management, LLC.
771.59K
4.64%
+309.05K
+66.82%
Sep 30, 2025
Centaurus Investments Limited
1.11M
6.66%
+475.10K
+75.12%
Dec 31, 2024
Rosalind Advisors, Inc.
918.67K
5.52%
-56.79K
-5.82%
Sep 30, 2025
Nir (Yehuda)
613.91K
3.69%
+62.60K
+11.36%
Mar 31, 2025
Lukach (Aharon)
299.55K
1.8%
-5.64K
-1.85%
Mar 31, 2025
Morgan Stanley & Co. LLC
202.12K
1.22%
+124.69K
+161.03%
Sep 30, 2025
Dafna Capital Management, LLC
207.90K
1.25%
--
--
Sep 30, 2025
Worth Venture Partners, LLC
293.54K
1.76%
-438.03K
-59.88%
Sep 30, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎์ด๋ฆ
๋น์จ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ฐฐ๋น๊ธ
๎์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
๋ ์ง
๋ฐฐ๋น๊ธ
๊ธฐ์ค์ผ
์ง๊ธ์ผ
๋ฐฐ๋น๋ฝ์ผ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ถํ
๎๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
Aug 30, 2023
Merger
30โ1
Aug 30, 2023
Merger
30โ1
Aug 30, 2023
Merger
30โ1
Aug 30, 2023
Merger
30โ1
๋ ์ง
๋ฐฐ๋น๋ฝ์ผ
์ ํ
๋น์จ
Aug 30, 2023
Merger
30โ1
Aug 30, 2023
Merger
30โ1
Aug 30, 2023
Merger
30โ1
Aug 30, 2023
Merger
30โ1
